Melson, Eka

Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome

Teede, H. J., Tay, C. T., Laven, J. J. E., Dokras, A., Moran, L. J., Piltonen, T. T., Costello, M. F., Boivin, J., Redman, L. M., Boyle, J. A., et al. (2023) · European Journal of Endocrinology

Ovarian function and disordersClinical practice guidelines implementation

Cited by 525

Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome

Teede, H. J., Tay, C. T., Laven, J., Dokras, A., Moran, L. J., Piltonen, T. T., Costello, M. F., Boivin, J., M. Redman, L., A. Boyle, J., et al. (2023) · Fertility and Sterility

Ovarian function and disordersClinical practice guidelines implementation

Cited by 417

What is the pipeline for future medications for obesity?

Melson, E., Ashraf, U., Papamargaritis, D., & Davies, M. J. (2025) · International Journal of Obesity

Pharmacology and Obesity TreatmentRegulation of Appetite and Obesity

Cited by 332

Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome

Teede, H. J., Tay, C. T., Laven, J., Dokras, A., Moran, L. J., Piltonen, T. T., Costello, M. F., Boivin, J., Redman, L. M., Boyle, J. A., et al. (2023) · Human Reproduction

Ovarian function and disordersClinical practice guidelines implementation

Cited by 244

Body image concerns in women with polycystic ovary syndrome: a systematic review and meta-analysis

Davitadze, M., Malhotra, K., Khalil, H., Hebbar, M., Tay, C. T., Mousa, A., PCOS SEva team, Robinson, L., Sheikh, J., Melson, E., et al. (2023) · European Journal of Endocrinology

Ovarian function and disordersEating Disorders and Behaviors

Cited by 57

Future therapies for obesity

Melson, E., Miras, A. D., & Papamargaritis, D. (2023) · Clinical Medicine

Pharmacology and Obesity TreatmentBariatric Surgery and Outcomes

Cited by 46

Oral glucagon-like peptide-1 receptor agonists and combinations of entero-pancreatic hormones as treatments for adults with type 2 diabetes: where are we now?

Gogineni, P., Melson, E., Papamargaritis, D., & Davies, M. (2024) · Expert Opinion on Pharmacotherapy

Diabetes Treatment and ManagementPharmacology and Obesity Treatment

Cited by 32